Carl Jeppson Company LLC – Trademark Portfolio

Entity Type: 16

Carl Jeppson Company LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 33 (Wine & Spirits) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MALÖRT and DO NOT ENJOY. RESPONSIBLY.. The owner is based in Chicago, IL.

1629 S. Clinton Street

Chicago, IL 60616

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Carl Jeppson Company LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

33
Wine & Spirits (1 filing)

Alcoholic beverages (except beers)

Frequently Asked Questions

How many trademarks does Carl Jeppson Company LLC have?

Carl Jeppson Company LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Carl Jeppson Company LLC file in?

Carl Jeppson Company LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 33 (Wine & Spirits). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Carl Jeppson Company LLC's most well-known trademarks?

Carl Jeppson Company LLC's registered trademark portfolio includes well-known marks such as MALÖRT and DO NOT ENJOY. RESPONSIBLY.. These are among 2 currently registered trademarks in the portfolio.

What is Carl Jeppson Company LLC's trademark registration success rate?

Carl Jeppson Company LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.